Changhai Hospital
Also known as: 11.Changhai Hospital | Changhai Hospital | Changhai Hospital Shanghai | Changhai Hospital, Shanghai, China | Changhai Hospital,Shanghai,China | Changhai houspital | Chanhai hospital | Cz Li | Department of Hematology, Changhai Hospital | Department of thyroid and breast surgery, Changhai Hospital | Guo ShiWei | Kai-Yang Lv | Neurology Department of Changhai Hospital | Neurosurgical Department of Changhai Hospital | Yiqi Du | Zhuan Liao
Highest phase reached
Phase 4
First clinical trial
Mar 31, 2008Last known activity
Dec 30, 2025
Timeline
1970s
- Jan 1, 1979
Changhai Hospital— Founded
Drugs by trial phase (160 distinct, 129 trials)
Phase 4 (33 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
- personalized neoantigen vaccine
- hyaluronic acid
- capecitabine
- cea car-t cells
- autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine
- 90-yttrium
- liocyx
- stem cells from human exfoliated teeth
- dental pulp mesenchymal stem cells
- car-cldn18.2 t-cells
- bcma/cd19 dual-target car-t
- ql1706
- cd19 car-nk cells
- cd70 car-t cells
- cd19-car-dnt cells
- +2 more
Other trials (41 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Acute Kidney Injury
- Adenocarcinoma
- Adenocarcinoma of Lung
- Adenoma
- Aneurysm
- Bile Duct Diseases
- Brain Neoplasms
- Breast Neoplasms
- Calculi
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Pancreatic Ductal
- Carcinoma, Renal Cell
- Cataract
- Colorectal Neoplasms
- Congenital Abnormalities
- Coronary Artery Disease
- Diabetes Mellitus, Type 1
- Diarrhea
- Edema
- Esophagitis
- Fibrosis
- Gastritis
- Gastroesophageal Reflux
- Gastrointestinal Hemorrhage
- Heart Diseases
- Hemorrhage
- Herpangina
- Hyperphosphatemia
- Intracranial Aneurysm
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Neoplasms
- Lung Injury
- Lung Neoplasms
- Macular Edema
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Osteoarthritis
- Osteoarthritis, Knee
- Overweight
- Pancreatic Diseases
- Pancreatic Neoplasms
- Pancreatitis
- Prostatic Neoplasms
- Radiculopathy
- Recurrence
- Renal Insufficiency, Chronic
- Respiratory Aspiration
- Stomach Diseases
- Subarachnoid Hemorrhage
- Thrombosis
- Triple Negative Breast Neoplasms
- Vascular Malformations
- Wounds and Injuries
Recent trials (50)
- NCT07298590OfficialEarly Phase 1Dec 30, 2025
- NCT07298590Lead sponsorEarly Phase 1Dec 30, 2025
- NCT07307456Sponsor investigatorPhase 2Dec 8, 2025
- NCT07307456Lead sponsorPhase 2Dec 8, 2025
- NCT07202559Lead sponsorN/ADec 1, 2025
- NCT07202559Sponsor investigatorN/ADec 1, 2025
- NCT07241468Lead sponsorEarly Phase 1Nov 30, 2025
- NCT07246096Lead sponsorEarly Phase 1Nov 20, 2025
- NCT07134218Lead sponsorPhase 2/Phase 3Oct 31, 2025
- NCT07088757Sponsor investigatorPhase 4Sep 15, 2025
- NCT07088757Lead sponsorPhase 4Sep 15, 2025
- NCT07156656CollaboratorPhase 4Sep 1, 2025
- NCT07036991OfficialPhase 4Jul 30, 2025
- NCT07036991Lead sponsorPhase 4Jul 30, 2025
- NCT06931873Lead sponsorEarly Phase 1May 20, 2025
Details
- Founded
- Shanghai, CN Jan 1, 1979
- Last known activity
- Dec 30, 2025